Sphingosine-1 Phosphate Receptor Modulators Increase In Vitro Melanoma Cell Line Proliferation at Therapeutic Doses Used in Patients with Multiple Sclerosis

INTRODUCTION: S1P(1) receptor modulators (S1P(1)-RM) are oral disease-modifying therapies (DMTs) for multiple sclerosis (MS). Several authorities have raised doubts that S1P(1)-RM are responsible for an increased risk of melanoma in patients with MS. We studied the in vitro effects of S1P(1)-RM on d...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruetsch-Chelli, Caroline, Okuda, Darin T., Rocher, Fanny, Tartare-Deckert, Sophie, Deckert, Marcel, Lebrun-Frenay, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837347/
https://www.ncbi.nlm.nih.gov/pubmed/36534273
http://dx.doi.org/10.1007/s40120-022-00429-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837347/
https://www.ncbi.nlm.nih.gov/pubmed/36534273
http://dx.doi.org/10.1007/s40120-022-00429-6

Ejemplares similares